HOME › DRUGS › DENILEUKIN DIFTITOX-CXDL
ACTIVE SUBSTANCE / INN

DENILEUKIN DIFTITOX-CXDL

Brand name(s): LYMPHIR
FDA LISTED
PRESCRIPTION
BLA761312
ACTIVE SUBSTANCE
Denileukin Diftitox-Cxdl
REGULATORS
FDA
SPONSORS / MAH
CITIUS PHARMS
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
LYMPHIRBLA761312CITIUS PHARMSPrescription

FULL INTELLIGENCE ON DENILEUKIN DIFTITOX-CXDL

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →